Current Report Filing (8-k)
May 19 2022 - 4:01PM
Edgar (US Regulatory)
0001680139
false
0001680139
2022-05-13
2022-05-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the
Securities Exchange
Act of 1934
Date of Report (Date of
earliest event reported): May 13, 2022
HealthLynked Corp.
(Exact name of registrant
as specified in charter)
Nevada |
|
000-55768 |
|
47-1634127 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
1265 Creekside
Parkway, Suite 302, Naples FL 34108
(Address of principal executive offices)
(800) 928-7144
(Registrant’s telephone
number, including area code)
N/A
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which
registered |
|
|
|
|
|
Item 8.01. Other Events.
On May 13, 2022 (the “Effective
Date”), HLYK Florida, LLC (“HLYK FL”), a Florida limited liability company and wholly owned subsidiary of
HealthLynked Corp., a Nevada corporation (the “Company”), acquired all of the outstanding equity interests of Aesthetic
Enhancements Unlimited (“AEU”), a Florida limited liability company providing minimally and non-invasive cosmetic procedures
(the “Purchase”).
As consideration for the Purchase,
the previous AEU equity interest holders received consideration of (i) $325,000 cash, (ii) the issuance of an aggregate of 792,394 restricted
shares of the Company’s common stock valued at $100,000 based on the closing price of the Company’s common stock on the business
day prior to the Effective Date, and (iii) the future partial satisfaction of certain outstanding debt obligations of AEU by the Company
in an amount up to $75,000 in cash.
AEU will be incorporated into
the Company’s Health Services segment following the Effective Date.
On May 17, 2022, the Company
issued a press release with respect to, among other things, the Purchase. A copy of the press release is filed
as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference.
Item 9.01 Financial Statements and Exhibits
EXHIBIT NO. |
|
DESCRIPTION |
|
Location |
99.1 |
|
Press release dated May 17, 2022 |
|
Filed herewith |
104 |
|
Cover Page Interactive Data file (embedded within the Inline XBRL document). |
|
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.
|
HEALTHLYNKED CORP. |
|
|
Date: May 19, 2022 |
/s/ George O’Leary |
|
George O’Leary |
|
Chief Financial Officer |
2
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Aug 2024 to Sep 2024
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Sep 2023 to Sep 2024